Univariate analysis of baseline variables related to first-year mortality following HDM-SCT
Baseline characteristic . | OR . | P . |
|---|---|---|
| Diuretic use | 0.3 | .001 |
| Weight gained, % | 292.8 | .002 |
| GFR | 0.01 | .002 |
| Troponin T (> 0.035 ng/mL) | 5.60 | .01 |
| NT-proBNP (> 332 pg/mL) | 6.22 | .03 |
| Organs involved | .03 | |
| Septal thickness | 9.94 | .05 |
| Alkaline phosphatase | 8.86 | .05 |
| Change in diuretic dose | 0.47 | .10 |
| Conditioning | .12 | |
| Albumin | 0.42 | .29 |
| Proteinuria | 2.49 | .36 |
| Age | 1.44 | .72 |
| Mobilization | .77 | |
| Sex | 1.13 | .78 |
| Ejection fraction | 1.42 | .80 |
| Pretransplant weight | 1.29 | .84 |
| Vascular involvement | 0.95 | .94 |
Baseline characteristic . | OR . | P . |
|---|---|---|
| Diuretic use | 0.3 | .001 |
| Weight gained, % | 292.8 | .002 |
| GFR | 0.01 | .002 |
| Troponin T (> 0.035 ng/mL) | 5.60 | .01 |
| NT-proBNP (> 332 pg/mL) | 6.22 | .03 |
| Organs involved | .03 | |
| Septal thickness | 9.94 | .05 |
| Alkaline phosphatase | 8.86 | .05 |
| Change in diuretic dose | 0.47 | .10 |
| Conditioning | .12 | |
| Albumin | 0.42 | .29 |
| Proteinuria | 2.49 | .36 |
| Age | 1.44 | .72 |
| Mobilization | .77 | |
| Sex | 1.13 | .78 |
| Ejection fraction | 1.42 | .80 |
| Pretransplant weight | 1.29 | .84 |
| Vascular involvement | 0.95 | .94 |